Splicing is the molecular editing step that removes non-coding introns from freshly made RNA transcripts and joins the protein-coding exons together. The machinery responsible, the spliceosome, must identify precise boundaries between exons and introns, most critically the 3′ splice site that marks the end of an intron. In most human genes, this task is made easier by the underlying nucleotide composition: exons tend to be rich in guanine and cytosine, the G and C of the DNA alphabet, while the surrounding introns are rich in adenine and thymine. That contrast gives the splicing machinery a clear signal of where exons begin and end. But a distinct subset of genes breaks this rule. In these genes, both exons and introns are GC-rich, producing a GC-leveled architecture in which the usual compositional contrast between coding and non-coding regions largely disappears.

That architectural quirk has consequences. When exons and introns carry similar GC content, the spliceosome loses one of its strongest clues for distinguishing exon from intron, and the 3′ splice sites in these genes tend to be cytosine-rich and depleted of thymine, features that make them intrinsically weak substrates for recognition by the splicing machinery. The new study set out to determine how cells manage to splice these difficult genes efficiently despite their unfavorable sequence landscape. The answer, the researchers report, lies in a compartment that has fascinated cell biologists for decades: the nuclear speckle.

Nuclear speckles are membraneless organelles, dense droplet-like structures within the nucleus that are packed with RNA-processing factors, including many components of the spliceosome. Rather than being passive storage depots, speckles are now understood to function as dynamic hubs for RNA metabolism, exchanging factors with nearby genes and concentrating the molecular tools needed for transcript maturation. Recent work has shown that speckles are largely organized by two large scaffold proteins, SON and SRRM2, and that genes located in close spatial proximity to speckles tend to be spliced more efficiently than genes farther away. What remained unclear was the molecular mechanism connecting that spatial coupling to the actual chemistry of splicing.

The Zhejiang University team, led by corresponding author Yafei Yin with important contributions from Xiaoyu Li, approached the question by combining acute protein depletion with a battery of genome-wide assays. Using the dTAG degron system, a technique that allows rapid and targeted destruction of a chosen protein inside living cells, the researchers generated cell lines in which SON could be eliminated on demand. They then profiled the consequences using 4sU-seq, which captures newly synthesized RNA and therefore reports directly on splicing efficiency in real time, along with CLIP-seq and TurboRIP-seq to map where SON binds and which RNA-protein complexes it associates with, U2 RAP-seq to follow the recruitment of the U2 spliceosomal component to pre-messenger RNA, and Pol II ChIP-seq to track the behavior of the RNA polymerase II enzyme that transcribes genes into RNA. All of the resulting datasets have been deposited in the NCBI Gene Expression Omnibus under accession number GSE325871, allowing other researchers to examine the raw evidence.

The data converged on a clear conclusion. When SON was removed, splicing defects appeared preferentially in GC-rich genes, precisely the subset whose weak, cytosine-rich and thymine-poor 3′ splice sites make them dependent on extra help. The mechanism the authors propose is that SON stabilizes the recognition of those weak splice sites, effectively propping up the first and most error-prone step of spliceosome assembly at GC-rich intron boundaries. In other words, SON does not change the sequence of the gene, but it changes the probability that the splicing machinery correctly interprets a difficult sequence, converting what would otherwise be inefficient and error-prone processing into fast, accurate exon joining.

This mechanism elegantly explains why GC-leveled genes cluster near nuclear speckles in the first place. If a gene’s splice sites are inherently weak, the gene benefits from sitting close to a reservoir of concentrated splicing factors, and SON, as a core scaffold of the speckle, appears to be the factor that translates physical proximity into biochemical support. The finding also assigns a concrete molecular role to SON that goes beyond its established architectural function in organizing speckle structure alongside SRRM2. SON, the study suggests, is not merely a beam holding the nuclear compartment together; it is an active participant in the splicing reactions that the compartment enables.

The implications reach beyond basic cell biology. SON has previously been implicated in human disease, and genes with GC-rich, GC-leveled architecture include many regulators of development and cell growth, so understanding how their splicing is safeguarded could illuminate why nuclear organization fails in certain disorders. The work also connects to a broader theme in modern biology: the recognition that genome function depends on spatial organization, with the position of a gene relative to nuclear bodies influencing how efficiently it is expressed. By identifying the sequence feature, the weak 3′ splice site, that makes a gene dependent on speckle proximity, the study provides a concrete molecular bridge between nuclear geography and RNA chemistry, a bridge that has been hypothesized but never resolved in such detail.

Technically, the study stands out for its use of complementary high-throughput methods applied after acute, rather than chronic, protein loss. Chronic depletion experiments can be confounded by secondary effects as cells adapt over days, whereas the dTAG system destroys SON within hours, allowing the researchers to observe the primary consequences of its absence. The combination of nascent RNA sequencing with crosslinking-based binding maps and polymerase occupancy data allowed the team to distinguish direct effects on splice-site recognition from indirect effects on transcription or RNA stability, strengthening the causal chain from SON binding to efficient splicing of GC-rich transcripts.

Open questions remain. The precise molecular contacts through which SON stabilizes 3′ splice-site recognition, whether through direct binding to the weak cytosine-rich sites, through recruitment of U2 snRNP components, or through both routes acting in concert, will require structural and biochemical follow-up. It also remains to be seen whether other speckle components, including the co-scaffold SRRM2, contribute redundant or specialized support for different classes of weak splice sites. Nevertheless, by demonstrating that a single nuclear speckle protein safeguards the splicing of an entire architectural class of genes, the study transforms nuclear speckles from a correlated curiosity into a mechanistically understood support system, and it gives researchers a new lens for examining how the architecture of the genome and the architecture of the nucleus co-evolved to make complex gene expression possible.

Subject of Research: Role of the nuclear speckle protein SON in the splicing of GC-rich genes

Article Title: Nuclear speckle protein SON safeguards efficient splicing of GC-rich genes

Article References: Fan, W., Zhou, Y., Zhang, X., Tong, C., Li, X., & Yin, Y. (2026). Nuclear speckle protein SON safeguards efficient splicing of GC-rich genes. Cell Research. https://doi.org/10.1038/s41422-026-01303-y

Image Credits: AI Generated

DOI: 10.1038/s41422-026-01303-y

Keywords: nuclear speckles, SON, RNA splicing, GC-rich genes, spliceosome, 3′ splice site, dTAG degron, 4sU-seq, CLIP-seq, nuclear organization, pre-mRNA processing, Cell Research

The spliceosome acts as a vital machinery, selectively excising the non-coding regions, or introns, from precursor mRNA transcripts. While the major spliceosome is relatively abundant and has been extensively studied, the minor spliceosome remains largely enigmatic, characterized by its lower prevalence and equally crucial role in gene expression. The identification of the minor spliceosome has long eluded researchers, but recent breakthroughs from the Galej Group at the European Molecular Biology Laboratory (EMBL) have shed light on its structure and function, specifically through the lens of the U11 small nuclear ribonucleoprotein (snRNP).

Understanding the structural biology of the minor spliceosome is crucial, as it maintains a pivotal role in the splicing pathway. The U11 snRNP, highlighted in the latest study published in the journal Molecular Cell, is one of five essential components of the minor spliceosome. This molecular assembly acts at the front lines of splicing, initiating the delicate process of intron selection which, after extensive investigation, has been identified as a critical factor for the expression of certain genes known as housekeeping genes. These genes play an indispensable role in cellular function and organismal survival, emphasizing the importance of studying this underappreciated spliceosomal counterpart.

The research conducted by the Galej Group involved meticulous biochemical and imaging techniques, particularly cryo-electron microscopy, which allowed for the determination of the U11 snRNP complex’s structure. The research elucidated a previously unknown mechanism by which this snRNP identifies the key ‘5’ splice site’—the specific locus on the pre-mRNA where intron removal begins. This structural analysis has brought significant insights into how the minor spliceosome operates in a cellular environment that is constantly inundated with a myriad of RNA sequences.

Spliceosomes, being large RNA-protein complexes, not only facilitate the removal of introns but also ensure that the splicing process occurs with remarkable precision. This precision is particularly vital for the recognition of rare minor introns, which represent a mere fraction of the total intron population within the transcriptome. The majority of introns processed by the major spliceosome are easily identifiable; conversely, minor spliceosomal introns pose a unique challenge due to their relative scarcity. The study emphasizes how the U11 snRNP uses a complex and finely-tuned architecture to navigate through the vast landscape of RNA, akin to locating a needle within a haystack.

Equally fascinating is the evolutionary narrative surrounding the minor spliceosome. It is posited that the major and minor spliceosomes diverged over 1.5 billion years ago, an evolutionary timeline that stretches the imagination and indicates a deep-rooted presence in eukaryotic cells. This evolutionary separation invites consideration of how these two spliceosomal systems have adapted to fulfill their respective roles in gene expression across various life forms. The work undertaken by the Galej Group not only contributes to our appreciation of this evolutionary tale but also lays the groundwork for extending research into other components of the minor spliceosome.

As the team’s research continues, it remains focused on uncovering additional insights into the splicing process, including the steps that follow the recognition of the intron. The transition from intron identification to its eventual excision is a complex sequence of events, with potential implications for understanding not only fundamental biology but also the pathological consequences of spliceosomal malfunctions that can lead to genetic disorders. This further exploration is underscored by Zhao’s recent award of the prestigious Marie Skłodowska-Curie grant, which will support ongoing investigations into the intricacies of the minor spliceosome’s functions.

If the major spliceosome has long been the star of splicing research, the minor spliceosome is now beginning to capture the spotlight. The emphasis on this molecular machinery opens doors to future research possibilities that may unearth novel therapeutic avenues for genetic disorders linked to aberrant splicing mechanisms.

Ultimately, the revelations stemming from the Galej Group’s research not only enhance our comprehension of the spliceosome’s structural diversity but also underscore its evolutionary significance in the grand scheme of molecular biology. The findings extend far beyond academia, potentially influencing prospective developments in medical science aimed at curing genetic disorders. As researchers build upon these insights, the world eagerly anticipates the outcomes of this exciting field, where answers to longstanding biological questions may redefine our understanding of genetics and human health.

The journey of understanding spliceosomal structures and functions has just begun, and with every new discovery, the tantalizing prospect of unraveling the complexities of gene expression looms larger. As we delve deeper into the inner workings of these molecular machines, we inch closer to unlocking the secrets of life encoded within our DNA.

This research serves as a reminder of the nuances of biological systems and the importance of foundational studies that may one day lead to breakthroughs in treating genetic conditions. With every structural insight gained, we enhance our grasp on the molecular grammar underpinning life itself and pave the way for future innovations in genetic therapeutics.

Subject of Research: Cells
Article Title: Structure of the minor spliceosomal U11 snRNP
News Publication Date: 13-Jan-2025
Web References: Molecular Cell
References: DOI 10.1016/j.molcel.2024.12.017
Image Credits: Credit: Jiangfeng Zhao/EMBL, Daniela Velasco/EMBL

Keywords: Spliceosomes, Gene splicing, Introns, Protein complexes, Molecular structure, Genetic disorders, Structural biology.